According to results of a Johns Hopkins collaborative study, men with lower cholesterol are less likely than those with higher levels to develop high-grade prostate cancer - an aggressive form of the disease with a poorer prognosis.
In a prospective study of more than 5,000 U.S. men, epidemiologists say they now have more evidence that among […]

continue reading from " Men with lower cholesterol less likely to develop high-grade prostate cancer "

According to results of a Johns Hopkins collaborative study, men with lower cholesterol are less likely than those with higher levels to develop high-grade prostate cancer - an aggressive form of the disease with a poorer prognosis.
Results of the current study are expected to be published online Nov. 3 in the journal Cancer Epidemiology, Biomarkers […]

continue reading from " Low cholesterol may shrink risk for high-grade prostate cancer "

Swedish researchers say that cholesterol is vital for brain development and functioning, and it’s needed to help form brain cells.
Despite of people live obsessed with the need to lower our cholesterol levels, this new study reminds us just how important it is for maintaining health. People who are on a strict diet to reduce their […]

continue reading from " Cholesterol is good for us "

An UK study warns that middle-aged male smokers with high blood pressure and raised cholesterol levels face dying about 10 years before healthier counterparts. The British Heart Foundation said it was an important reminder for everyone over 40 to have a heart health check.
The study, published in the British Medical Journal, was set up in […]

continue reading from " Smokers can live 15 years longer if they quit "

A recent study published in the Journal of the American College of Cardiology has concluded that driving down cholesterol levels actually increases the risk of cancer.
Tufts University School of Medicine researchers found that among people taking “statin” drugs - like Lipitor and Zocor - there was a higher rate of cancer.
Although the link between the […]

continue reading from " Low cholesterol levels can increase risk of cancer "

Data from a case-control study TAT American Society of Clinical Oncology (ASCO) showed prostate cancer mortality risk declined by 50% in men taking statins for reasons unrelated to cancer, data from a case-control study showed.
According to Stephen Marcella, M.D., of the University of Medicine and Dentistry of New Jersey School of Public Health in Piscataway, […]

continue reading from " Prostate Cancer deaths lower in users of cholesterol lowering drugs "

People prescribed widely used cholesterol-busting drugs called statins may be more likely to feel fatigued than those who don’t, a new study finds.
But the findings don’t prove that the medications make people tired, and heart specialists remain skeptical about the study, which focused on two statins, Pravachol and Zocor.
The researchers found that people on simvastatin […]

continue reading from " Cholesterol Drugs Linked to Increased Fatigue "

According to a new study from Columbia University Medical Center researchers, a history of diabetes and elevated levels of cholesterol, especially LDL cholesterol, are associated with faster cognitive decline in patients with Alzheimer’s disease.
These results add further evidence of the role of vascular risk factors in the onset and progression of Alzheimer’s disease.
Findings indicate that […]

continue reading from " Diabetes and elevated levels of cholesterol linked to cognitive decline in Alzheimer’s "

Current research suggests that lowering cholesterol may block the growth of prostate tumors. The related report by Solomon et al, “Ezetimibe Is an Inhibitor of Tumor Angiogenesis,” appears in the March 2009 issue of The American Journal of Pathology.High cholesterol not only leads to atherosclerosis and heart disease, but may also contribute to cancer growth […]

continue reading from " Lowering your cholesterol may decrease your risk of prostate cancer "

A recent study conducted by the team of Dr. Nabil G. Seidah, Director of the Biochemical Neuroendocrinology Research Unit at the IRCM, shows for the very first time that the degradation by PCSK9 of the LDLR receptor, which is responsible for removing the bad cholesterol (LDL-cholesterol) from the bloodstream, may be inhibited by a third protein, […]

continue reading from " Big discovery in the control of bad cholesterol "